Krystal Biotech Inc (KRYS) valuation · P/E 40, rev $389.1M
Krystal Biotech Inc (KRYS) P/E 40, rev $389.1M.
| Metric | Value |
|---|---|
| P/E | 40 |
| Market cap | $10.17B |
| Revenue | $389.1M |
| P/S | 26.1 |
| P/B | 7.5 |
KRYS valuation FAQ
What is KRYS's P/E ratio?
Krystal Biotech Inc (KRYS) trailing P/E is 40 on the latest cached fundamentals snapshot.
What is KRYS's market cap?
Krystal Biotech Inc (KRYS) market cap is $10.17B on the latest cached fundamentals snapshot.
What is KRYS's latest revenue?
Latest cached Krystal Biotech Inc (KRYS) revenue was $389.1M. Statements: https://lician.com/financials/krys
What is KRYS's price-to-sales ratio?
Krystal Biotech Inc (KRYS) price-to-sales (P/S) is 26.1, cached market cap $10.17B divided by revenue $389.1M.
What is KRYS's price-to-book ratio?
Krystal Biotech Inc (KRYS) price-to-book (P/B) is 7.5 on the latest cached fundamentals snapshot.
How many KRYS valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for Krystal Biotech Inc (KRYS): P/E, Market cap, Revenue, P/S, and P/B.
Where is KRYS valuation listed?
Cached valuation multiples for Krystal Biotech Inc (KRYS) are listed at https://lician.com/valuation/krys.
Not investment advice. Cached rows, not a live tape.